A systematic review of the benefits and harms of dipeptidyl peptidase‐4 inhibitor for chronic kidney disease

Discussion DPP‐4 inhibitors demonstrated beneficial effects on the glycemic control for diabetic patients with CKD without causing any additional adverse effects. However, a definitive conclusion has yet to be drawn due to serious methodological problems and a small number of studies.
Source: Hemodialysis International - Category: Hematology Authors: Tags: Original Article Source Type: research